We compared three serum ferritin radioimmunoassay kits and one noncommercial RIA for ferritin quantitation, with regression analysis of results for sera from 35 ostensibly healthy subjects. There was a good correlation (p <0.00 1) between these various RIAs, but the slope of the regression line varied widely, most probably because of lack of standardization of the serum ferritin assay. Determination of the ferritin content of purified samples of tissue ferritin revealed that the kits differ in specificity, differences for purified human spleen ferritin and human liver ferritin being larger than those for normal sera. Removing the iron from purified liver ferritin increased antiserum binding in two of the kits by twofold, but had no effect in two other kits. We conclude that commercial RIA methods for serum ferritin differ in specificity, and that this difference is related to the source of ferritin used in the production of the antibodies.
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Estimation of ferritin in serum by radioimmunoassay (RLA) currently is widely used as a diagnostic tool. Low ferritin values are associated with iron deficiency. High ferritin concentrations (hyperferritinemia) can result from such conditions as iron overload, malignant disease, and tissue damage such as occurs in hepatitis (1, 2).
Ordinarily, ferritin in serum is heterogeneous, as has been demonstrated by isoelectric focusing of serum samples (3) (4) (5) . In pathological conditions, however, a particular form of ferritin may predominate: decreased binding to concanavalin A (6), appreciable iron content (7) (8) (9) , and anomalous reaction with antibodies to tissue ferritins (10) (11) (12) have all been reported. Variations in the characteristics of ferritin in pathological sera may be related to its origin from a population of pathological cells. These tissue ferritins differ in iron content, isoelectric point, immunological properties, and subunit composition (13, 14) .
Because commercial RIAs involve use of antibodies to ferritins from different tissues, purified by different methods, the antibodies supplied in the kits may have different specificities. We checked on this by comparing results obtained with three commercial RIA kits and one noncommercial kit for ferritin in sera from healthy subjects and for ferritins extracted from different tissues. was developed at the University Hospital in Utrecht, The Netherlands, as described elsewhere (15) . Table   1 lists the main featuresof these kits.
Materials and Methods
Materials
All procedures were done according to instructions supplied with the kits. In brief, the procedures were as follows:
Clinical Assays kit. Mix a 100-zL serum sample with 100 L of antiferritin antiserum and 500 .zL of tracer and incubate for 3 h in a thermostated waterbath at 37 #{176}C. Then add 500 zL of precipitating goat anti-rabbit IgG serum and continue the incubation for 30 mm. Centrifuge all tubes in one run at 1000 X g for 15 mm, carefully decant the supernatant fluid, and measure the radioactivity of the pellet.
Ramco kit. Place 10 zL of serum sample and 200 iL of in- Utrecht kit. Place 100 L of serum sample in tubes coated with antiferritin IgG, incubate for 18 h at 4 #{176}C, then decant and wash the walls of the tubes four times with saline. Add 100 zL of radiolabeled antiferritin IgG to the tubes, and incubate for 4 h at room temperature.
Decant, wash the tubes three times, then count their radioactivity.
Serum Specimens
The "normal" sera were prepared from blood collected from laboratory staff and from regular blood donors selected without conscious bias. The sera were divided into 1-mL samples, stored at -20 #{176}C, and assayed within six months.
Procedures
Preparation of ferritins from various tissues.
Tissue from human heart, liver, and spleen was obtained within 24 h postmortem, from the Department of Pathology, University Hospital, Utrecht.
To prepare tissue ferritin extracts, we suspended 50 g of tissue in 50 mL of water to which benzamidine (1 mmol/L) and phenylmethylsulfonylfluoride (0.5 mmol/L) had just been added, then homogenized the suspension in a "Braun" blender. The particulate fraction was removed by centrifugation at 20000 X g for 30 mm. To purify ferritin from the tissue homogenates, we used the following general procedure: heat treatment, 10 mm at 73 #{176}C; precipitation with half-saturated ammonium sulfate; ultracentrifugation (100 000 X g, 180 mm); ion-exchange chromatography on DEAE-Sepharose 6B and gel filtration on Sepharose 6B. The detailed procedure will be reported elsewhere (manuscript in preparation).
We h we replaced thedialysis fluid with1 L ofa mixtureofdiethyl barbiturate, 40 mmol/L, and NaCl, 0.1mol/L (pH 6.8). This dialysis fluidwas changed three times (total dialysis interval, fourdays). A control ferritin sample was preparedaccording to essentially the same procedure,but withoutthioglycolic acid.The ferritin preparations were subjected to polyacrylamide gradient slab gel (40-300 g/L) electrophoresis. The protein staining indicated a major band of Mr = 450 000 and one minor band, of high molecular mass, for both preparations. The bands stained also for iron in the control ferritin sample, while no iron staining was visible for apoferritin.
Natural liver apoferritin.
We isolated apoferritin from partly purified liver ferritin that had not been subjected to ultracentrifugation. The ferritin was crystallized from a 200 g/L solutionof CdSO4 and subjectedto sucrosegradient 
Statistical Analysis
We compared results with the kits for control sera by using regression analysis accordingto the method of Deming and Morgan (18) , which takes into account the errorin both variables
(19).
To examine whether a particular kit showed an abnormal sensitivity for a particular tissue ferritin, we used the following procedure:
From the result of a tissue ferritin quantitation in "kitA" (x)we calculated which result was tobe expectedin "kit B" (Ypredicted), based on theregression ofthe comparison between "kit A" and "kit B" for the control sera. The underlying assumption was that if two kits in a particular kit combination had comparable affinities, the values for serum ferritin and tissue ferritin should be indistinguishable.
To test this hypothesis, we estimated the significance of the difference between the predicted y-valueand the actually observed yvalue by using the following formula (20):
S, , and n are derived from the regression of the control sera(seeTable 2 forexplanation ofthesymbols).
Other methods.
Ferritin protein was measured according to Schalterle and Pollack (21) . Ferritin iron was measured with bathophenanthroline accordingto Harris (22) . Radioactivity was measured with a gamma counter (Trigamma 600;
Baird Atomic Inc., Bedford, MA 01730). a Sera from healthy laboratory staff and from regular blood donors were assayed for serum ferritin according to the Instructions of the manufacturers. All the serum ferritin values fell within the specified normal ranges of the kits. The assay of the serum samples was allocated over three different assay runs. Each sample was assayed induplicate inone runforallfourkits inthesame week. The symbols represent: B0: intercept of the linear relationship between x and y, B1: slope ofthe linear relationship between x and y; deviation from regression; mean ofthex dataset;S: variance ofthe x data set; p2: correlation coefficient; n: Hoechst kit showed the largest variability, as judged from the large deviation of regression in all combinations with the Hoechst kit ( Table 2) .
Results
Quantitation of ferritin antigen in normal sera. The ferritinconcentration in identicaldilutionsof a singlenormal
number
Quantitation of ferritin antigen in kit standards and in tissue preparations.
We examined whether the antisera used in the kits had different specificities. Ferritin antigen was quantified in kit standards, tissue extracts, and purified tissue ferritins ( Table 3 ). The kit standards responded almost identically as for the normal sera except that the Utrecht kit was less sensitive for the Ramco standard. Also, ferritin measured in tissue extracts did not reveal large differences among the kits when compared with normal sera. Purified ferritins, however, showed considerable variation when assayed with the different kits. A significantly higher sensitivity for the Ramco and Hoechst kit was observed against purified liver and spleen ferritin preparations. Moreover, the Hoechst kit showed an unusually high reactivity for the more aggregated forms of purified liver ferritin. In contrast, purified heart ferritin did respond like serum ferritin in all kit combinations. Liver apoferritin also responded more like serum ferritin, except for a higher sensitivity of the Utrecht kit for native apoferritin. Table 2 ). Those samples for which a particular 
Discussion
There was a good correlation among the three commercial radioimmunoassay kits and one noncommercial kit for ferritin determinationin normal serum. Absolutevalues, however, variedwidely, reflecting thelackofstandardization ofserum ferritin determinations. We have demonstratedherethatthe differences betweenthekits cannotbe explained solely on the basisofquantitative differences. Purified ferritins, especially from liver and spleen, demonstrated much larger differences between the kits thencouldbe explained with the differences found innormal sera. Moreover,theeffect ofremovalofiron The ferritin content In a purified liver ferritin sample (white bail and in an iron-poor ferrltin sample (apoferritin, cross-hatched bar) derived from the same source was quantitated in duplicate in one run for all four kits. This ferritin preparation was purified from a different liver from those listed in Table 2 had no effect on ferritin antigen icity intwo ofthekitswhile the two other kits showed a twofold increase in antiserum binding.
Our results for normal sera are consistent with previous reports where other kits for the measurement of serum ferritin were compared (23) (24) (25) (26) (27) . These investigators also found considerable quantitative differences, which were ascribed to the lack of ferritin standardization.
However Ferritin purified by CdSO4 crystallization such as the human liver ferritin standard of the Clinical Assays kit, the human spleen ferritin standard of the Ramco kit, and the natural apoferritin preparation all responded like serum ferritin in the kit combinations. This is in harmony with another study, in which crystalline liver and spleen ferritin were shown to respond identically in a sandwich-type RIA for serum ferritin (29) . The unusually high sensitivity of the Hoechst kit for liver ferritin may be in part due to trapping of ferritin oligomers in the antiserum-coated beads in this assay, causing excessive binding of radiolabeled antiserum. In the Ramco kit, however, in which antiserum-coated beads alsoareused,the effect was less dramatic.
Porter (30) demonstrated an inverse relationship between ferritin iron content and ferritin reactivity in a competitive RIA in which crystalline human spleen ferritin was the standard. We found the same trend with the Clinical Assays kit and the Utrecht kit but not with the Hoechst and Ramco kits.
This is another indication that the kits differ in their reactivity for the various antigenic sites on ferritin.
In conclusion, the observed differences between RIA kits for ferritin in normal serum could be explained by quantitative differences inthekitstandards. But inpathological serawith high ferritin content-in which a large contribution of tissue ferritin to the circulating ferritin may be expected-the different specifities of the RIA kits should also be considered.
